1646.1000 -9.00 (-0.54%)
NSE Oct 16, 2025 09:49 AM
Volume: 155.7K
 

1646.10
-0.54%
Motilal Oswal
Sun Pharma (SUNP) reported a slight miss at the operational level for
4QFY24. This was due to lower-than-expected sales in the ROW market and
higher-than-expected opex for the quarter.
Sun Pharmaceutical I.. has an average target of 2050.25 from 8 brokers.
More from Sun Pharmaceutical Industries Ltd.
Recommended